CS Site-Specific Factor 22
Multigene Signature Method
Notes
**Note 1**: Multigene signatures or classifiers are assays of a panel of genes from a tumor specimen, intended to provide a quantitative assessment of the likelihood of response to chemotherapy and to evaluate prognosis or distant recurrence. Oncotype DX and MammaPrint (also called MammoPrint) are two commercially available genomic tests. **Note 2**: Code the type of test performed. The same test should be used to record information in CS Site-Specific Factors 22 and 23. **Note 3**: This information may not be available at diagnosis and may require follow-up with the physician.Default
999NAACCR Item
NAACCR #2876Metadata
CCCR_IVA_COLLECT_IF_AVAILABLE_IN_PATH_REPORTCOC_CLINICALLY_SIGNIFICANT
SEER_CLINICALLY_SIGNIFICANT
| Code | Description |
|---|---|
| 010 | Oncotype DX |
| 020 | MammaPrint (MammoPrint) |
| 030 | Other |
| 040 | Test performed, type of test unknown |
| 988 | Not applicable: Information not collected for this case (If this information is required by your standard setter, use of code 988 may result in an edit error.) |
| 997 | OBSOLETE DATA CONVERTED V0203 See code 040 Test ordered, results not in chart |
| 998 | Test not done (test not ordered and not performed) |
| 999 | Unknown or no information Not documented in patient record |